Patents by Inventor Aaron Lackner

Aaron Lackner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORGANIC ELECTROLUMINESCENT DEVICE
    Publication number: 20200144505
    Abstract: The present application relates to a blue light-emitting organic electroluminescent device (OLED) having an anode, a cathode, at least one blue light-emitting layer and at least one hole-transport layer, wherein the at least one blue light-emitting layer comprises an elongated bis-indenofluorene derivative as a main component and wherein the at least one hole-transport layer comprises a polymer with non-conjugated units as a main component as well as to a method for producing the organic electroluminescent device.
    Type: Application
    Filed: June 29, 2018
    Publication date: May 7, 2020
    Applicant: Merck Patent GmbH
    Inventors: Katja Scheible, Beate Burkhart, Nils Koenen, Lara-Isabel Rodriguez, Sebastian Meyer, Rouven Linge, Miriam Engel, Aaron Lackner, Holger Heil
  • Platelet-activating factor receptor antagonists
    Patent number: 9029377
    Abstract: Cyclohexyl sulfonamide compounds which are platelet-activating factor (PAF) receptor antagonists. Said compounds may be useful, for example, for the treatment of atherosclerosis or other PAF-mediated disorders, including inflammatory, cardiovascular, and immune disorders.
    Type: Grant
    Filed: June 28, 2010
    Date of Patent: May 12, 2015
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Anthony Ogawa, Feroze Ujjainwalla, Lin Chu, Bing Li, Lan Wei, Jinyou Xu, Hyun Ok, Aaron Lackner, Ihor Kopka
  • PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONISTS
    Publication number: 20120108595
    Abstract: Cyclohexyl sulfonamide compounds which are platelet-activating factor (PAF) receptor antagonists. Said compounds may be useful, for example, for the treatment of atherosclerosis or other PAF-mediated disorders, including inflammatory, cardiovascular, and immune disorders.
    Type: Application
    Filed: June 28, 2010
    Publication date: May 3, 2012
    Inventors: Anthony Ogawa, Feroze Ujjainwalla, Lin Chu, Bing Li, Lan Wei, Jinyou Xu, Hyun Ok, Aaron Lackner, Ihor Kopka